2,5-dioxopyrrolidin-1-yl formate

Catalog No.: 
ACWFRU618
CAS No.: 
17592-54-0
Molecular Formula: 
C5H5NO4
Molecular Weight: 
143.10
2,5-dioxopyrrolidin-1-yl formate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$70.00In stockInquiry
250mg95%$93.00In stockInquiry
1g95%$259.00In stockInquiry
5g95%$753.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,5-dioxopyrrolidin-1-yl formate
IUPAC Name2,5-dioxopyrrolidin-1-yl formate
MDL No.-
Molecular FormulaC5H5NO4
Molecular Weight143.10
SMILESO=CON1C(CCC1=O)=O
InChI KeyHTHSIXDWFKZUGO-UHFFFAOYSA-N
Synonym2,5-dioxopyrrolidin-1-yl formate;2,5-Pyrrolidinedione, 1-(formyloxy)-
CAS No.17592-54-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACWFRU618 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPOQL635 route compound structure diagram
    ACPOQL6356066-82-6In Stock
  2. Then
  3. ACWFRU618 route product structure diagram
    ACWFRU61817592-54-0In Stock
Inquiry

2. ACWFRU618 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACPOQL635 route compound structure diagram
    ACPOQL6356066-82-6In Stock
  6. Then
  7. ACWFRU618 route product structure diagram
    ACWFRU61817592-54-0In Stock
Inquiry

3. ACWFRU618 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWFRU618 route product structure diagram
    ACWFRU61817592-54-0In Stock
Inquiry

Comments (0)